Holen Sie sich die Stockscreener-App
10.75
0.37%
-0.04
Handel nachbörslich:
10.75
Schlusskurs vom Vortag:
$10.79
Offen:
$10.83
24-Stunden-Volumen:
2.84M
Relative Volume:
5.42
Marktkapitalisierung:
$498.83M
Einnahmen:
$681.50M
Nettoeinkommen (Verlust:
$15.70M
KGV:
31.62
EPS:
0.34
Netto-Cashflow:
$36.60M
1W Leistung:
+4.07%
1M Leistung:
-9.89%
6M Leistung:
-35.36%
1J Leistung:
-52.37%
1-Tages-Spanne:
$10.55
$11.16
1-Wochen-Bereich:
$10.26
$11.16
52-Wochen-Spanne:
$9.303
$25.36
Avanos Medical Inc Stock (AVNS) Company Profile
Firmenname
Avanos Medical Inc
Sektor
Branche
Telefon
844-428-2667
Adresse
5405 WINDWARD PARKWAY, ALPHARETTA, GA
Vergleichen Sie AVNS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVNS
Avanos Medical Inc
|
10.75 | 500.68M | 681.50M | 15.70M | 36.60M | 0.34 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 1.41B | 577.90M | 6.95 |
Avanos Medical Inc Stock (AVNS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-25 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-22 | Eingeleitet | CL King | Buy |
| 2021-08-04 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-04-13 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-11-07 | Herabstufung | Stifel | Buy → Hold |
| 2019-11-06 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-08-21 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Avanos Medical Inc Aktie (AVNS) Neueste Nachrichten
Avanos Medical Inc. Hits Oversold Level on RSI IndicatorMarket Risk Analysis & Free Daily Entry Point Trade Alerts - 선데이타임즈
Avanos Medical’s SWOT analysis: stock performance amid transition By Investing.com - Investing.com Nigeria
Avanos Medical’s SWOT analysis: stock performance amid transition - Investing.com
What Technical Tools Say About Avanos Medical Inc. RecoveryWeekly Stock Opportunity Radar Scanner Activated - 선데이타임즈
Avanos Medical, Inc. (NYSE:AVNS) Q2 2025 Earnings Call Transcript - MSN
Is Avanos Medical Inc. benefiting from innovation trendsTop Stocks with 10x Roadmap - thegnnews.com
Candlestick Signal Suggests Reversal in Avanos Medical Inc.Entry Alert Based on Volume Spikes Detected - metal.it
Is Avanos Medical Inc. stock a good dividend stockFree Buy and Hold Suggestions - mustnews.co.kr
Should I buy Avanos Medical Inc. stock nowReturn-Optimized Stock Portfolio - kangso.co.kr
Avanos Medical’s Earnings Call: Strategic Growth Amid Challenges - TipRanks
Avanos Medical 2025 Q2 Earnings Sharp Net Loss Amid Revenue Growth - AInvest
Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down - Yahoo Finance
Avanos maintains $665M–$685M revenue target amid HA divestiture and tariff impact - MSN
Avanos Medical shares fall 1.92% intraday after appointing Scott Galovan as Chief Financial Officer. - AInvest
Disposable Pain Pumps Market Set to Witness Significant Growth - openPR.com
Avanos Medical Second Quarter 2025 Earnings: US$1.66 loss per share (vs US$0.094 profit in 2Q 2024) - Yahoo Finance
Avanos Medical Appoints New CFO Amid Financial Challenges - The Globe and Mail
Avanos Medical net loss hits USD 76.8M in Q2 2025 - Medical Buyer
Avanos Medical, Inc.'s (NYSE:AVNS) Revenues Are Not Doing Enough For Some Investors - simplywall.st
Avanos Medical: Q2 Earnings Snapshot - New Haven Register
Avanos Medical Inc (AVNS) Q2 2025 Earnings Call Highlights: Strong Sales Growth Amid Strategic ... By GuruFocus - Investing.com Canada
Avanos Medical Inc (AVNS) Q2 2025 Earnings Call Highlights: Stro - GuruFocus
Avanos Medical Reports Q2 2025 Financial Results - TipRanks
Avanos Medical shares rise 1.52% after-hours after appointing Scott Galovan as CFO. - AInvest
Avanos Medical, Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:AVNS) - Seeking Alpha
Earnings call transcript: Avanos Medical beats Q2 2025 earnings, stock tumbles - Investing.com
Avanos (AVNS) Q2 2025 Earnings Call Transcript - AOL.com
Avanos Q2 2025 slides: Revenue grows while profits decline, shares tumble - Investing.com Canada
Avanos (AVNS) Q2 2025 Earnings Call Transcript - The Motley Fool
Avanos Medical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Avanos Medical (AVNS) Misses Q2 Earnings Estimates - sharewise.com
Avanos Medical, Inc. Announces Second Quarter 2025 Results | AVNS Stock News - GuruFocus
Avanos Medical Q2 net sales rise 1.9%, beat expectations - MarketScreener
AVNS names new CFO, divests HA line; CEO joins board in 8-K filing | AVNS SEC FilingForm 8-K - Stock Titan
Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors - WV News
Avanos Medical earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Avanos Medical, Inc. Announces Second Quarter 2025 Results - PR Newswire
Avanos (AVNS) Welcomes Scott Galovan as New CFO - GuruFocus
Should I hold or sell Avanos Medical Inc. stock in 2025Overwhelming profit margins - Jammu Links News
Avanos Medical Inc. Stock Analysis and ForecastInvest smarter and grow your wealth faster - Jammu Links News
How many analysts rate Avanos Medical Inc. as a “Buy”Invest smarter with daily stock recommendations - Jammu Links News
Is Avanos Medical Inc. a good long term investmentHigh-performance stocks for savvy investors - Jammu Links News
What are the latest earnings results for Avanos Medical Inc.Skyrocketing returns - Jammu Links News
What are analysts’ price targets for Avanos Medical Inc. in the next 12 monthsAccelerated investment success - Jammu Links News
Finanzdaten der Avanos Medical Inc-Aktie (AVNS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):